STAB VIDA

STAB VIDA

Pesquisa biotecnológica

Your Easy Genetics Laboratory from Portugal

Sobre nós

Our mission is to be “your easy genetics laboratory”. Whether you are in Lisbon, Porto, Milano, Rio de Janeiro, Madrid, Cordoba, etc, we want to create an easily crossable bridge with you (a patient, a doctor, a scientist, a veterinary professional or a student), on which data and information may flow easily, supported by solid laboratories and staff from STAB VIDA to provide you with the results you need. If the last few decades were characterized by the emergence of information and telecommunication technologies, the 21st century will be remarked by the advances in gene technology. The growth of gene technology is creating platforms for new products and markets. The genetic testing market utilises genomic sequences for diagnosis and treatment of diseases and other genetic characteristics. Its high business potential has prompted governments to consider research in genomics and proteomics a strategic priority. This is the challenging environment where STAB VIDA operates and intends to enhance its performance by exploring new opportunities. In a more broader sense, our mission consists of harnessing innovation and adopting new technologies in biotechnology through research and development, technology transfer, and proper commercialization of products and services in the global market.

Setor
Pesquisa biotecnológica
Tamanho da empresa
11-50 funcionários
Sede
Caparica
Tipo
Empresa privada
Fundada em
2001
Especializações
Genotyping, Oligonucleotides, Bioinformatics, Metabolomics, Monoclonal antibodies, Probes, DNA sequencing, Paternity testing, Bird sex determination, PCRs, SARS-Cov-2 Detection, Next Generation Sequecing e Fragments Analysis

Localidades

  • Principal

    Madan Parque, Rua dos Inventores, Salas 2.18 e 2.19

    Caparica, 2825-182, PT

    Como chegar

Funcionários da STAB VIDA

Atualizações

Páginas semelhantes

Visualizar vagas

Financiamento

STAB VIDA Total de 1 fase

Última rodada

Conceder

US$ 68.343,00

Ver mais informações no Crunchbase